Navigation Links
Baron & Budd, P.C., Announces $3.6 Million Settlement in California Asbestos Lawsuit

SAN FRANCISCO, Nov. 5 /PRNewswire/ -- The law firm of Baron & Budd, P.C., is announcing a $3.6 million settlement in an asbestos exposure lawsuit filed on behalf of an 81-year-old man who worked in the San Francisco area. The settlement was reached a day before the jury would have determined the fate of the defendants, all asbestos joint compound companies.

Attorneys John Langdoc and Eric Brown from Baron & Budd represented Martin Lujan. The final settlement was reached after two weeks of trial in Judge Thomas Mellon's courtroom in San Francisco.

The defendants in this trial were: Bondex, Kaiser-Gypsum, Hamilton Materials, and Kelly Moore.

"Eric, John and our entire trial team worked incredibly hard to find and interview witnesses; obtain access to internal corporate files which showed these companies knew their products could cause cancer and chose to keep selling them; and trace Mr. Lujan's career working in the construction of over 100 buildings around these products. In the end the investigation uncovered that Mr. Lujan had been exposed to asbestos, a known carcinogen, in the form of joint compound, for over 15 years while working in the construction industry," says Russell W. Budd, managing partner of Baron & Budd.

In addition to uncovering that Mr. Lujan had been exposed to asbestos from these companies' joint compounds, the Baron & Budd trial team also presented evidence that the companies were told by the U.S. government that working for only four days around joint compounds would result in an unreasonable risk of cancer to workers, and that it has been known for decades that there is no safe level of exposure to asbestos.

Just months before he was diagnosed with mesothelioma, his doctors noted that Mr. Lujan was in excellent health. When his doctors informed him that his mesothelioma was caused by asbestos, he initially had no idea that his work as a carpenter and construction worker had exposed him to dangerous materials.

"Mr. Lujan's family is appreciative of all the hard work put in by the Baron & Budd team to uncover what products were responsible for Mr. Lujan's asbestos cancer," says John Langdoc.

The effects of asbestos exposure, including the onset of diseases like mesothelioma and other asbestos cancers, can take decades to surface. Nearly forty years passed before Mr. Lujan began exhibiting symptoms of mesothelioma. He is currently fighting the cancer from his home in the San Francisco area.

About Baron & Budd, P.C.

For 30 years, the law firm of Baron & Budd, P.C. has championed the rights of people and communities harmed by corporate misconduct. With more than 50 attorneys and offices in California, Texas and Louisiana, Baron & Budd enjoys a national reputation as a leader of the plaintiffs' bar. The firm represents individuals with mesothelioma and other diseases caused by asbestos; leukemia caused by benzene; injuries caused by other toxic substances and unsafe pharmaceuticals; water authorities seeking clean-up costs for drinking water contamination; securities investors defrauded by corporate wrongdoing; and consumers in class actions.

For more information, please contact Bruce Vincent at 800.559.4534 or Susan Knape at 214.523.6226.

SOURCE Baron & Budd, P.C.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and ... their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took ... the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: